23andMe said it's started exploring strategic alternatives, including a possible sale. The company released third-quarter ...

FORT WORTH, Texas - PharmChem, Inc. (OTC: PCHM), known for its drug-detecting sweat patches and currently trading at $3.07 near its 52-week low, announced Monday that its Board of Directors is ...

23andMe Holding Co. ( ME, Financials) announced that its board's Special Committee is reviewing strategic alternatives, ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

AB Novaturas The top management of the tour operator AB Novaturas (hereinafter referred to as Novaturas) has passed a decision to conduct an analysis of strategic alternatives. For this purpose, a ...

The top management of the tour operator AB Novaturas (hereinafter referred to as Novaturas) has passed a decision to conduct an analysis of strategic alternatives. For this purpose, a contract was sig ...

There is no deadline or definitive timetable set for completion of the strategic alternatives review process and there can be no assurance that this process will result in the Company pursuing a ...

The top management of the tour operator AB Novaturas (hereinafter referred to as Novaturas) has passed a decision to conduct an analysis of strategic alternatives. For this purpose, a contract was ...

Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that the Veradigm Board of Directors (the “ ...

The company's management and Board of Directors are now exploring strategic alternatives to maximize shareholder value, which may include potential acquisitions or business combinations.